Fundamental Data for BRKR

BRUKER COR(NSDQ:BRKR)

Bruker BioSciences is the parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. The company develops, manufactures and markets worldwide advanced X-ray solutions for the three-dimensional structure determination of biological and chemical compounds, as well as for advanced materials research and analysis.

# Employees: 4400

Address: 40 Manning Road,Billerica,MA,USA

Phone: 978 663-3660

Fax: 978 667-0985

Website: www.bruker-biosciences.com

Email: Michael.Willett@Bruker.com

Sector: Computer and Technology

Industry: INSTRU-SCIENTFC

Executive Officers

Frank H. Laukien Ph.D. (Chmn.; Presi.; C.E.O.)

William J. Knight (C.F.O.; Princ. Acctg. Off.)

Brenda J. Furlong (Dir.)

Daniel S. Dross (Dir.)

Collin D???Silva (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 3/9/2010

Mean EPS (Next Qtr): $0.19

Mean EPS (Year): $0.40

Mean Estimate(Long Term): $22.40

P/E Ratio(Based on EPS estimate): 28.880

Number of Estimates: 4

Shares Performance

Period	BRKR	Compare to S&P
YTD	185.89 %	136.61 %
4 Weeks	8.35 %	7.18 %
12 Weeks	16.78 %	10.10 %

Shares Information

Analyst Coverage: Y

Avg Volume: 578770

Shares Outstanding: 164M

Market Cap: $1.90B

52 Week High: $11.60

52 Week Low: $3.35

P/E Ratio: 28.170

PEG Ratio: 1.290

Split: On 1/1/1990 BRKR split by factor of 0.100

Earnings Performance

EPS Growth in Last Quarter: 25.00 %

EPS Growth in Last Year: -9.09 %

Sales Growth in Last Quarter: 4.99 %

Sales Growth in Last Quarter: 9.52 %

Financials

Qtr Book Value: $5.08

Cash Flow/Share: $18.22

Change in Payout Ratio: 0.000

Price/Sales: 1.780